The changing field of drug development
16 Jul 2012
The changing field of drug development
Application of next generation sequencing
Next generation sequencing and WIN therapeutics
Identifying targets with systems medicine
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Relapse and survival of adolescent and young adult leukaemia patients
Problems in the structure of clinical trials
New approaches to personalised medicine
Highlights and goals of IMPAKT 2012
Innovation in molecular imaging
Cancer diagnosis in teenagers
Developing new support services for young people with cancer